Page last updated: 2024-10-22

amifostine anhydrous and Myocardial Ischemia

amifostine anhydrous has been researched along with Myocardial Ischemia in 1 studies

Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.

Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rolleman, EJ1
Forrer, F1
Deckers, J1
de Groot, H1
Valkema, R1
de Jong, M1
Krenning, EP1

Other Studies

1 other study available for amifostine anhydrous and Myocardial Ischemia

ArticleYear
Anaphylactoid reaction from amifostine.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2007, Volume: 82, Issue:1

    Topics: Amifostine; Diagnosis, Differential; Humans; IgA Vasculitis; Myocardial Ischemia; Radiation-Protecti

2007